Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
about
Prevention of bipolar disorder in at-risk children: Theoretical assumptions and empirical foundationsA systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulationThe neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulationNeuropeptides in depression: role of VGFThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisGenomic studies of mood disorders -- the brain as a muscle?Epigenetic mechanisms in mood disorders: targeting neuroplasticitycAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in ratsUnderstanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia.Protective actions of ovarian hormones in the serotonin system of macaquesOvarian steroids decrease DNA fragmentation in the serotonin neurons of non-injured rhesus macaques.Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.Antidepressant effects of resveratrol in an animal model of depressionMood-stabilizers target the brain arachidonic acid cascade.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsChronic administration of bacopa monniera increases BDNF protein and mRNA expressions: a study in chronic unpredictable stress induced animal model of depression.Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression.Neuroplasticity and major depression, the role of modern antidepressant drugsGlutamatergic modulators: the future of treating mood disorders?Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorderMolecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.Cellular plasticity and resilience and the pathophysiology of severe mood disorders.Neural plasticity: consequences of stress and actions of antidepressant treatmentRegulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor traffickingOvarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques.The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.Trends in the development of new antidepressants. Is there a light at the end of the tunnel?Estrogen effects on the forced swim test differ in two outbred rat strains.Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stressNeural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targetsTreadmill exercise alleviates chronic mild stress-induced depression in rats.Duality of Antidepressants and Neuroprotectants.Escitalopram and enhancement of cognitive recovery following stroke.Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats.Neuroinflammation, neurodegeneration, and depression.
P2860
Q22251374-60CE0DFC-0864-4D9A-AFD8-808A9D82455CQ22305782-9342B595-604D-4C97-A26D-767CE5E6EE59Q24613593-086D44D0-2302-46C4-98B8-AE50232307D2Q24647788-9E212313-A64B-4049-A7E7-B5490DF1844CQ24651407-DB9017FB-656B-4E65-B51D-E9FC6BE4B23CQ24797578-972CCBC3-EF4A-4CB6-B5FC-5A6D76E12D71Q27021810-577FACD0-1726-46A3-B33E-2270C9D75A55Q28602109-F9C8CD0B-1B9A-40D8-9BD1-158BADF52E9AQ30428091-D7DEA1F7-1F4B-402E-9205-D0E8473A46A4Q30480102-D988BB25-20DB-4ED6-BCC2-4C9149A638F0Q33435072-1114B40B-ECF1-4C7F-B7DC-E635622045B2Q33509986-D241C179-52A1-49B3-BDC0-3524A6930449Q33553152-B3601E0F-A8E5-46C0-8F0F-BE7F172CE81EQ33663230-B20B5E0A-2B14-4453-A4CC-3EE2FF83704AQ33671302-AA42E472-E14A-417D-BABF-3870B882AAEFQ33929918-47BD2B7A-87E4-4E48-BE4C-5FBF162D1BA1Q34012247-5C8A99C3-0D47-4624-BC87-77C94DCFD594Q34128077-50D5D21A-1EA1-45DD-956D-4DCF782DD1DBQ34381499-D2835643-60D7-4868-828D-31D5E1003478Q34398007-3C806A04-031D-4275-93E8-8CF14BA3EE7CQ34548121-ABABC7EC-1DCB-49F3-8561-E33E9CFF6DB9Q34994209-84D86173-D69C-49EE-8C4E-8AD8C814BFBCQ35157755-25B35F95-B080-4816-9C5F-1080F557790FQ35197096-73CB6667-07C3-48EF-BA4E-7F3A17490E99Q35212429-D642CF2A-7365-46B9-BC7F-DE8F26F9B0D5Q35236446-3E414704-48C5-4DA6-8E91-4B9A98BE9AF3Q35236784-2321712C-AD38-4B5F-BFD6-7B8AEA6FEB76Q35236802-8EF47695-1779-46B3-BA09-11D7CEA9AF9BQ35236806-7AABF442-3289-4715-9C75-3FF54880D3FAQ35544686-642A964D-883C-49ED-AEA6-875BFE97218BQ35563633-F7E79EC3-02C5-43F4-9EA1-DBBC9943DC8DQ35743638-BC20C2B0-FFB5-4494-8B29-19F61793447DQ35857011-A7CF36A7-3362-4A1B-A3FA-6DC8C25BDFE8Q36259063-F8A3221B-23D2-4CB6-81A0-42B493B755BBQ36401907-020033A1-D9ED-4B4D-ACF7-7D7D8C6D8F0BQ36420482-C15072B0-7F98-45DB-9141-0F49600D0204Q36944840-AAC613B7-4286-45DA-A530-4204FC578CBDQ37032754-763E163A-00D8-454C-A039-29ADE2E82000Q37086344-E4F36EC1-B0B7-42EB-91CF-4ECECB9B4FE4Q37116106-38B15FBB-6CBF-487A-8D7F-B778B735635E
P2860
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@ast
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@en
type
label
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@ast
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@en
prefLabel
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@ast
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@en
P1476
Impairments of neuroplasticity ...... lopment of novel therapeutics.
@en
P2093
P577
2001-01-01T00:00:00Z